MiR-205-5p/GGCT attenuates the growth and metastasis of papillary thyroid cancer by regulating CD44
Accordingly, GLP-1 RAs have reduced the risk of atherosclerotic cardiovascular events in a number of randomized outcomes trials in patients with type 2 diabetes
Listietoja: Tutkimusjohtaja, dosentti Markku Lhteenvuo, It-Suomen yliopisto / Niuvanniemen sairaala, [email protected], +358 29 5242 202 Professori Jari Tiihonen, It-Suomen yliopisto / Niuvanniemen sairaala ja Karoliininen instituutti, [email protected] ja [email protected] +358 50 341 8363 Tutkimusartikkeli: Taipale H, Taylor M, Lhteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Tiihonen J: Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study
A daily intake of 2-4g of L-carnitine is recommended 6
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments